FDA Generics Office Sets Aspirational Goal To Clear Unmeasured ANDAs
This article was originally published in The Pink Sheet Daily
Executive Summary
Office of Generic Drugs restructures again and adds specialist who helped relieve supplement backlog to improve ANDA review process.